Log in
Enquire now
DEM BioPharma

DEM BioPharma

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

OverviewStructured DataIssuesContributors

Contents

dembiopharma.com
Is a
Company
Company
Organization
Organization

Company attributes

Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Legal Name
DEM Biopharma, Inc.
Email Address
recruiting@dembiopharma.com
Investors
Longwood Fund
Longwood Fund
Insight Partners
Insight Partners
Alta Partners
Alta Partners
Astellas Venture Management
Astellas Venture Management
Emerson Collective
Emerson Collective
Pfizer Venture Investments
Pfizer Venture Investments
UTokyo Innovation Platform
UTokyo Innovation Platform
Alexandria Venture Investments
Alexandria Venture Investments
Total Funding Amount (USD)
70,000,000
Latest Funding Round Date
June 23, 2022
Latest Funding Type
Series A
Series A

Other attributes

Latest Funding Round Amount (USD)
70,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like DEM BioPharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.